Protocol of OGSG 1901: a phase II trial of ramucirumab plus irinotecan for patients with early relapsed gastric cancer during or after adjuvant docetaxel plus S - 1 therapy.
Toshifumi YamaguchiHiasto KawakamiDaisuke SakaiYukinori KurokawaToshio ShimokawaMasahiro GotoTaroh SatohPublished in: BMC cancer (2022)
This study was registered in the Japan Registry of Clinical Trials ( jRCTs05119071 , October 6, 2019).